Gamma Investing LLC Harmony Biosciences Holdings, Inc. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 282 shares of HRMY stock, worth $10,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
282
Previous 139
102.88%
Holding current value
$10,944
Previous $4.67 Million
82.26%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
228Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$435 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$226 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$137 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$101 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$97.4 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.3B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...